FDA Considers Revoking Pfizer’s Covid Vaccine Approval for Under-5s: What This Means for Pediatric Health and Pharma Investors
Pfizer’s Covid-19 vaccine for healthy children under 5 is on the brink of losing FDA authorization—a development that could reshape pediatric vaccination strategies and ripple through the biotech and healthcare investment landscape. At Extreme Investor … Read more